Scholars Central

ArticlePublished 2015

Promising SINEs in the Treatment of Pancreatic Cancer

Authors: Asfar S Azmi, Yosef Landesman, Erkan Baloglu, Amro Aboukameel, Irfana Muqbil, Michael Kauffman, Philip A Philip, Sharon Shacham, Ramzi M Mohammad

Journal of the Pancreas

Volume 16 · Issue 4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pancreatic cancer remains a deadly disease in urgent need of newer therapeutic modalities. Pancreatic tumors are very heterogeneous and carry alterations in many critical pathways (i.e. harboring a robust biological network) rendering the design of therapy against a single pathway unrealistic. The disease requires a broad form of therapy that can target the activation of multiple tumor suppressor proteins simultaneously. It has been consistently shown in pancreatic cancer biopsies that there is an over-expression of the nuclear exporter protein exportin 1 also known as Chromosome maintenance region 1. Nuclear exporter protein exportin 1 is recognized to export major nuclear residing tumor suppressor proteins causing their functional inactivation through their mislocalization to the cytoplasmic compartment. This makes exportin 1 an attractive therapeutic target in pancreatic cancer. Supporting this we have clearly demonstrated that targeted inhibition of exportin 1 by our specific inhibitors of nuclear export can restore the function of multiple tumor suppressor proteins leading the pancreatic cancer cell death and tumor inhibition in orthotopic models. Additionally, studies have demonstrated that specific inhibitors of nuclear export synergize with gemcitabine and nab-paclitaxel leading to enhanced pancreatic cancer growth inhibition, apoptosis, and disintegration of cancer stem cell mimicking spheroids. Collectively these studies have lead to a Phase Ib/II clinical evaluation of specific inhibitors of nuclear export with GEM and nab-paclitaxel in patients with metastatic pancreatic cancer (ClinicalTrials.gov Identifier: NCT02178436). In this mini-review we highlight the promising specific inhibitors of nuclear export in pancreatic cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of the Pancreas.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of the Pancreas
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Asfar S Azmi”
  • BylineArticles whose byline prints “Yosef Landesman”
  • BylineArticles whose byline prints “Erkan Baloglu”
  • BylineArticles whose byline prints “Amro Aboukameel”
  • BylineArticles whose byline prints “Irfana Muqbil”
  • BylineArticles whose byline prints “Michael Kauffman”
  • BylineArticles whose byline prints “Philip A Philip”
  • BylineArticles whose byline prints “Sharon Shacham”